(Q42549459)

2 November 2017

Lactate-induced anxiety after imipramine and diazepam treatment (English)

1 reference

2 November 2017

0 references

Pohl R

1

1 reference

2 November 2017

Balon R

series ordinal

2

1 reference

2 November 2017

Berchou R

series ordinal

3

1 reference

2 November 2017

Lycaki H

series ordinal

4

1 reference

2 November 2017

1 January 1994

1 reference

2 November 2017

1 reference

2 November 2017

1

1 reference

2 November 2017

54-63

1 reference

2 November 2017

2

1 reference

Biological correlates of lactate sensitivity in panic disorder.

2 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Differential reactivity to lactate infusions: the relative role of biological, psychological, and conditioning variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate- and isoproterenol-induced panic attacks in panic disorder patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate-Induced Anxiety: Therapeutic Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

The diagnostic utility of lactate sensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate vulnerability after alprazolam versus placebo treatment of panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Response to sodium lactate infusion in alcoholics with panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Biological markers in panic states: lactate-induced panic and mitral valve prolapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Behavioral biochemical and neuroendocrine concomitants of lactate-induced panic anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate infusions and panic attacks: do patients and controls respond differently?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Fading of therapeutic effects of alprazolam in agoraphobia. Case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Discontinuation of alprazolam treatment in panic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate vulnerability of remitted panic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Hemodynamic, ventilatory, and biochemical responses of panic patients and normal controls with sodium lactate infusion and spontaneous panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Ventilatory physiology of patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Imipramine and chlordiazepoxide in depressive and anxiety disorders. II. Efficacy in anxious outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Anxiety and the Effects of Sodium Lactate Assessed Clinically and Physiologically

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate provocation of panic attacks. I. Clinical and behavioral findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

The Hamilton Anxiety Scale: reliability, validity and sensitivity to change in anxiety and depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Withdrawal syndrome with gradual tapering of alprazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Diazepam and Propranolol in Panic Disorder and Agoraphobia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate Metabolism in Anxiety Neurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Gravity feed administration of sodium lactate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

The β-Receptor: Isoproterenol Anxiety States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Long-term Therapeutic Use of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Panic disorder: response to sodium lactate and treatment with antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Imipramine and alprazolam effects on stress test reactivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lorazepam vs. alprazolam in the treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Panic attack frequency and vulnerability to anxiogenic challenge studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Response of panic disorder to fixed doses of alprazolam or imipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Effects of laboratory-induced panic-anxiety on subsequent provocative infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Lactate-induced panic and beta-adrenergic blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Behavior Therapy, Supportive Psychotherapy, Imipramine, and Phobias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Imipramine and alprazolam treatment of lactate-induced acute endogenous distress in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Pairwise multiple comparison procedures: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANXI.3070010204

21 January 2018

Identifiers

DOI

10.1002/ANXI.3070010204

1 reference

2 November 2017

1 reference